In this report, we showed that EZH2 promoted the proliferation of keratinocyte through KLK8, and inhibition of EZH2 had a therapeutic effect on psoriasis in imiquimod-induced psoriasis-like mouse model. Here, EZH2 is linked to psoriasis.